SCHEMBL4181727

SCHEMBL4181727

[C]1=CC=CN2OCC=C12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2016225 0.60
Potassium Ion SCHEMBL1220491 0.35
SCHEMBL23964 0.31
SCHEMBL1190870 0.31
SCHEMBL237328 0.31
Potassium Ion SCHEMBL25364189 0.29
Water SCHEMBL18733 0.29
Potassium Ion SCHEMBL135 0.29
Potassium Ion SCHEMBL7893963 0.29
Water SCHEMBL490048 0.29

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2739144-A1 COMPOUNDS AND THERAPEUTIC USES THEREOF Alzheimer's Institute of America, Inc. (US) 2014-06-11 EP claimed
WO-2012177782-A1 COMPOUNDS AND THERAPEUTIC USES THEREOF MYREXIS, INC. (US) 2012-12-27 WO claimed
WO-2024097296-A1 ANTI-VIRAL COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2024-05-10 WO disclosed
US-20140349989-A1 COMPOUNDS AND THERAPEUTIC USES THEREOF ALZHEIMER'S INSTITUTE OF AMERICA (US) 2014-11-27 US disclosed
EP-2739144-A1 COMPOUNDS AND THERAPEUTIC USES THEREOF Alzheimer's Institute of America, Inc. (US) 2014-06-11 EP disclosed
WO-2012177782-A1 COMPOUNDS AND THERAPEUTIC USES THEREOF MYREXIS, INC. (US) 2012-12-27 WO disclosed
US-20090137637-A1 Tetrazolyl-Methylene Amino Acid Derivatives PFIZER INC. (US) 2009-05-28 US disclosed
EP-1828162-A1 TETRAZOLYL-METHYLENE AMINO ACID DERIVATIVES Warner-Lambert Company LLC (US) 2007-09-05 EP disclosed
WO-2006061706-A1 TETRAZOLYL-METHYLENE AMINO ACID DERIVATIVES WARNER-LAMBERT COMPANY LLC (US) 2006-06-15 WO disclosed